Ho Carole's Form 4 filing
Denali Therapeutics Inc. (DNLI) · filed Aug 22, 2024
- Accession no.
- 0001714899-24-000194
- Filed
- Aug 22, 2024
- Trade date
- Aug 20-21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $549.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ho CaroleCIK 0001724605 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | Common Stock | SSaleDisposed | −2,453 | $23.79 | −$58,356.87 | 138,815 | Direct | |
| Aug 21, 2024 | Common Stock | SSaleDisposed | −14,098 | $24.41 | −$344,132.18 | 124,717 | Direct | |
| Aug 21, 2024 | Common Stock | SSaleDisposed | −5,907 | $24.96 | −$147,438.72 | 118,810 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.